ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000275.1|Tetracenomycin_1 # 59 # 739 # -1 # ID=1_1;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.715	BGC0000275.1|Tetracenomycin_1 	59	739	-	Loose	375	37.3502	nalD	42.22	3000819	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGACTCCGCCGAAACCGACACCCCCAGCACCCGCAGCACCCCCAACGGCCCCGGCCTGCGCCAGCGGAAGCTGCGCCGTACGCGTGATCAGCTGATCCGCGAGGCCCTGGAGCTGTTCCTGGCGCAGGGTTACGAGCACACGACCGTGGAGCAGATCGCCGAGGCGGTCGAGGTGCATCCGCGCACGTTCTTCCGCCACTTCGCCAGCAAGGAGGAGGTGGCCCTCACCCCCATCAGCGCCATCGACGAGGCGTTCCTCGCCGCGCTGGAGGTCCGGCCGGCGGGCGAGAACCCGCTGCAGGCCATGAGCGGTGCCTTCCGGGCCGTCCTTGGGCGCGTGCGCGACGGTGAACTGGAGGGCGTGGACGGCGCGTTGCACATGGCGATGATGCGGCTGGTCGAGCGCACCCCCGGGCTCCTCGCGGAGTACCTGCGGCGCAGCGAGGAGATGGAGGGCCGACTCGCCCGGATCATCGCCGCGCGTGAGGGCGTCGACCTGGACGACGACTTCCGTCCGCGGTTCATCGTGGCGGTGTTCAAGGCGGTCGGCCGCGTCGTCAGCCGGGAGTGGTACCTGCGCGCCGACACGGATCTGGAGGCGCTCTCCGTGGCGTTCGAGTCCGCTCTGGACTCGCTGCGGCCGGAGTTGTTCGCCGACTGGCGGCGCCCGGGGGCCTGA	VDSAETDTPSTRSTPNGPGLRQRKLRRTRDQLIREALELFLAQGYEHTTVEQIAEAVEVHPRTFFRHFASKEEVALTPISAIDEAFLAALEVRPAGENPLQAMSGAFRAVLGRVRDGELEGVDGALHMAMMRLVERTPGLLAEYLRRSEEMEGRLARIIAAREGVDLDDDFRPRFIVAVFKAVGRVVSREWYLRADTDLEALSVAFESALDSLRPELFADWRRPGA	MRRTKEDSEKTRTAILLAAEELFLEKGVSHTSLEQIARAAGVTRGAVYWHFQNKAHLFNEMLNQVRLPPEQLTERLSGCDGSDPLRSLYDLCLEAVQSLLTQEKKRRILTILMQRCEFTEELREAQERNNAFVQMFIELCEQLFARDECRVRLHPGMTPRIASRALHALILGLFNDWLRDPRLFDPDTDAEHLLEPMFRGLVRDWGQASSAP	106.60	gnl|BL_ORD_ID|2335|hsp_num:0	1213			27	162	erythromycin; ciprofloxacin; tetracycline; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; aztreonam; colistin A; colistin B; ampicillin; nalidixic acid; panipenem; ticarcillin; trimethoprim-sulfamethoxazole
BGC0000275.1|Tetracenomycin_2 # 878 # 2494 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.705	BGC0000275.1|Tetracenomycin_2 	878	2494	+	Loose	600	184.496	Acinetobacter baumannii AmvA	28.71	3004577	protein homolog model	n/a	n/a	macrolide antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGCACGGAAACGCACGACGAGCCGTCAGGCGTCGCACACACCCCCGCTTCCGGTCTGCGTGGACGTCCCTGGCCGACCCTGCTCGCGGTCGCGGTCGGCGTGATGATGGTGGCTCTGGACAGCACCATCGTCGCCATCGCCAACCCGGCCATCCAGCAGGACCTCCACGCCTCGCTGGCCGATGTGCAGTGGATCACCAACGGCTACCTGCTGGCGCTCGCGGTCTCCCTGATCACCGCCGGCAAACTGGGCGACAGGTTCGGGCACCGGCAGACCTTCCTGGTCGGAGTGGCGGGCTTCGCCGTCACCTCCGCGGCCATCGGCCTGTCCGGCAGCGTCGCGGCGATCGTCGTCTTCCGCGTTCTCCAGGGCCTGTTCGGCGCTCTGATGCAGCCGTCGGCGCTGGGCCTGCTGCGGGTCACGTTCCCGCCCGGCAAGCTCAACATGGCGATCGGCATCTGGAGCGGCGTGGTCGGCGCCTCGACCGCAGCCGGACCGATCATCGGCGGGCTCCTGGTGCAGCACGTCGGCTGGGAGGCGGTCTTCTTCATCAATGTGCCGGTCGGCCTCGCGGCACTCGTCGCCGGCCTCGTCATCCTGACCGACGCGCGCGCCGAACGCGCCCCGAAGTCCTTCGACGTCTCCGGCATCGTGCTCCTGTCCGGGGCCATGTTCTGCCTGGTGTGGGGTCTGATCAAGGCTCCGGCCTGGGGCTGGGGCGACCTGCGGACGCTGGGCTTCCTGGCCGCCGCCGTGCTCGCCTTCGCCGGATTCACACTGCGGGAGAGCAGGGCCACCGAGCCGCTGATGCCGCTCGCCATGTTCCGTTCCGTGCCGCTGTCCGCGGGCACCGTGCTCATGGTCCTGATGGCGTTCTCGTTCATCGGCGGACTCTTCTTCGTCACCTTCTACCTGCAGAACGTCCATGGCATGAGCCCGGTCGAGAGCGGTGTGCACCTGCTGCCGCTCACCGGCATGATGATCGTCGGCGCCCCCGTGTCCGGCATCGTGATCAGCCGGTTCGGACCAGGCGGGCCGCTGGTGGTGGGCATGCTCCTGACGGCGGCGTCCCTGTGGGGGATGTCGACGCTGGAAGCGGACAGCGGTATGGGGATCACCTCGCTCTGGTTCGTGCTGCTGGGTCTCGGTCTCGCGCCGGTGATGGTGGGGACGACGGACGTCATCGTCAGCAACGCCCCGGCCGAACTGGCCGGTGTGGCCGGTGGTCTTCAGCAGTCCGCGATGCAGGTCGGCGGAAGTCTCGGCACCGCCGTACTCGGTGTCCTCATGGCCTCCCGGGTCGGCGACGTCTTCCCCGACAAGTGGGCGGAGGCGAACCTGCCGCGGGTGGGTCCGCGGGAGGCCGCGGCGATCGAGGACGCGGCCGAGGTGGGAGCCGTCCCGCCGGCCGGCACCCTCCCCGGCCGGCACGCCGGGACGCTCTCCGAGGTGGTCCACTCCTCGTTCATCTCGGGGATGGGGCTGGCCTTCACCGTGGCCGGTGCCGTCGCGCTCGTGGCCGCCGCCGTCGCCCTGTTCACCAGGAAGGCCGAGCCCGACGAGAGGGCCCCGGAGGAATTCCCGGTCCCGGCGTCCACGGCAGGGCGGGGCTGA	MSTETHDEPSGVAHTPASGLRGRPWPTLLAVAVGVMMVALDSTIVAIANPAIQQDLHASLADVQWITNGYLLALAVSLITAGKLGDRFGHRQTFLVGVAGFAVTSAAIGLSGSVAAIVVFRVLQGLFGALMQPSALGLLRVTFPPGKLNMAIGIWSGVVGASTAAGPIIGGLLVQHVGWEAVFFINVPVGLAALVAGLVILTDARAERAPKSFDVSGIVLLSGAMFCLVWGLIKAPAWGWGDLRTLGFLAAAVLAFAGFTLRESRATEPLMPLAMFRSVPLSAGTVLMVLMAFSFIGGLFFVTFYLQNVHGMSPVESGVHLLPLTGMMIVGAPVSGIVISRFGPGGPLVVGMLLTAASLWGMSTLEADSGMGITSLWFVLLGLGLAPVMVGTTDVIVSNAPAELAGVAGGLQQSAMQVGGSLGTAVLGVLMASRVGDVFPDKWAEANLPRVGPREAAAIEDAAEVGAVPPAGTLPGRHAGTLSEVVHSSFISGMGLAFTVAGAVALVAAAVALFTRKAEPDERAPEEFPVPASTAGRG	MQKKWLILTIIVLIYLPVTIDATVMHVATPSLSAALNLTANQLLWIIDIYSLIMAGLILPMGALGDRIGFKKLLFIGTAVFGVGSLAAAFSPTAYALIASRAILGLGAAMLIPATLSGIRNAFTEEKQRNFALGIWSTVGGGGAAFGPLVGGFVLEHFHWGAVFLINIPIILAVLVMIVMIIPKQQEKTDQPINLGQALVLVVAILSLIYSIKSAMYNFSVLTVVMFVVGISTLIHFIRSQKRATTPMIDLELFKHPVISTSIVMAVVSMIALVGFELLLSQELQFVHGFSPLQAAMFIIPFMIAISLGGPLAGICLNKWGLRRVSSLGILVSALSLWGLAQLNFSTDHFLAWTCMVFLGFSIEIALLASTAAIMSSVPPQKASAAGAIEGMAYELGAGLGVAIFGLMLSWFYSRSIILPAELPSNLIEKASISIGETMQLASNLENPLGGQLIVVAQQAFSYAHSWVLTLSAICFFLLTVFVWFSFPKKVN	109.35	gnl|BL_ORD_ID|2718|hsp_num:0	3280			6	1230	erythromycin; acriflavine
BGC0000275.1|Tetracenomycin_3 # 2609 # 3421 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.654	BGC0000275.1|Tetracenomycin_3 	2609	3421	-	Loose	550	26.5646	IMI-18	32.5	3006182	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	IMI beta-lactamase	ATGGGTGAAACGATCCGGCTGACCGGCGTACACGAGACGCTGCTCGCCACACTTCAGGCCCGTGCCCTGGACAATCGACAACCGCGACCCGTGCTGGGGGACGCGACGGCGGAGGAGCTGCTGCGCCGCATCGACTACGACTTCAGCCGCATCAGAACAGCCACCAAGGACATGCGGATCGTGACGTTCCGCGCCAGGAAGCTCGACGAGTGGGCCGGTCGATTCCTCGCGGTCCATCCGGACGCGGTGGTGCTGCACCTCGCATGCGGGCTGGACAGCCGGGCATTCCGGATGGACGTGCCCGACACAGTGGAATGGATCGACGTCGACGTCCCGGACGTCATCGAACTGAGGAGCCGGCTCTATCCCGAACGCGACGGATACCGGATGATCGGAGCGTCGGTCACCACGGAGGACTGGCTGGACACGGTGCCCCGCAACCGGCCGGCGCTCGTGGTCGCCGAAGGGCTGACGCCCTATCTCCGGGAAGCAGACGGAGAGGAAATGCTCCGGCGGGTGATCCGGCACCTTCCGACGGGTGCGGTCATGTTCGACGCCGTACTCCCGTGGACCCTTCGATTCGCCAAATATTCACAACTTCTGCGCGCCACGGGCGCCACCTTCGGATGGGGAATCGGAAATCCCCGCTCCCTGGAGAGCAGGGTGCCGGGATTACGGTTCCAGGAGCAGTGGTCCATGCTCGATTCCCCGTTTCTCGCCGACGCCCGCCCCGTCGAGAAATGGGTGGGAGCCGGCATGCGCAGCATTCCGCAACTGCGTTTCGCACACCGGCTGCTGCGTTACACCTTCTGA	MGETIRLTGVHETLLATLQARALDNRQPRPVLGDATAEELLRRIDYDFSRIRTATKDMRIVTFRARKLDEWAGRFLAVHPDAVVLHLACGLDSRAFRMDVPDTVEWIDVDVPDVIELRSRLYPERDGYRMIGASVTTEDWLDTVPRNRPALVVAEGLTPYLREADGEEMLRRVIRHLPTGAVMFDAVLPWTLRFAKYSQLLRATGATFGWGIGNPRSLESRVPGLRFQEQWSMLDSPFLADARPVEKWVGAGMRSIPQLRFAHRLLRYTF	MSLNVKPSRIAILFSSCLVSISFFSQANTKGIDDIKNLETDFNGRIGVYALDTGSGKSFSYKANERFPLCSSFKGFLAAAVLKRSQDNQLSLNQIVNYNTRSLEFHSPITTKYKDNGMSLGDMAAAALQYSDNGATNIILERYIGGPEGMTKFMRSIGDEDFRLDRWELDLNTAIPGDERDTSTPAAVAKSLKTIALGNILSEREKETYQTWLKGNTTGAARIRASVPSDWVVGDKTGSCGAYGTANDYAVVWPKNRAPLIISVYTTKYEKEAKHEDKVIAEASRIAIDNLK	92.47	gnl|BL_ORD_ID|3603|hsp_num:0	4672			717	837	
BGC0000275.1|Tetracenomycin_4 # 4053 # 5639 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.733	BGC0000275.1|Tetracenomycin_4 	4053	5639	+	Loose	900	113.235	iri	28.7	3002884	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGGAGAAGCACCGGGGAACCACGGTCCTGACCCGGGCCTCGGGGATCAGCTCCCGCACGATGGAACTGTTGCGGGGCGTCGGCCTGGAACGGACCGTGATCGAGCGCGGGCCGAAACTCGTCGAGGGAGCCCGCTGGCGGGAGCTCGGCCAGCCGGCGGACCAGATCCCCTGGGTCGTCATCCGGGCCAACGGCCTGCACGACCTGGAGAACGCGGTGACCGTCGAGGAACCCTCGCTCGACGTCGGCCACCTCAGCCCCACCCGCCCCTACTGGTGCGGGCAGGACCGGCTGGAACCCATCCTCCGCGACGAGGCCGTCCGCCGTGGGGCCCGCATCGACTTCAACACCCGCATGGAGGCGTTCACGGCGGACGAGAGCGGGGTCACCGCCACGATCGTCGACCAGGCCACCGGCGAGCAGAGCACGGTCCGCGCCCGGTACCTGATCGCGGCGGACGGGGTGCGCAGCCCGGTGCGGGAGACGCTGGGGATCACGCGCACCGGGCACGGCACGATCGGCAACGCCATGAGCGTCCTGTTCAAGGCGGACCTGCGGGACACCGTCAAGGGCCGGCGCTTCGTCATCTGCTACCTGCCGAACCCCGACGAGCCCGGCGTCCTCCAGCTCCCGGAGGTGCCGGCCGTCCTCCAGCTCTTCGACGAGGACCGCTGGATCTTCGGCTTCTTCTTCGACCCCCGCGAGACCTCGCCCGAGCAGTTCACCGACGAGCGCTGCGCGCAGATCATCCGGACCGCGACCGGGCTCCCCGGCCTCCCGGTCGAGGTGCAGATGGCCAGGCCCTGGGAGATGTCCCACAACAGTGCCCGCTCCTACCGCAGCGGCCGGGTCTTCCTGGCCGGCGACGCCGCCCACGTGCACCCACCGGCCGGTGCCTTCGGAGCGAACGGCGGTATCCAGGACGCCCACAACCTGGCCTGGAAGCTGGCGGCCGTCCTGAAGGGAACGGCCGGCGACGCCCTGCTCGACACCTACGAGCAGGAACGCCTGCCGATCGGTGCCGCCGTCGCCGACCAGGCGTGGATCCGGCACACCTGGAGGCTGAACGACTCCGAGGAGCTGCGCCGCGCGCTGCGCGAGTCGACGCTGGTCGCCACCGGTTACCGGTACACCTCCGACGCGGTCCTCGGTGCCGCCTACCCGGAGCCCATCCCCGCGGCGCACGACCTCACCGGCCGGCCGGGGTACCGCGTGCCCCACGTCTGGCTGGGCCGGGGCGGGGAGCGCGTCTCGACGGTCGACCTCGGCGGGGACGCGTTCGTCGTGCTCGCCGGGCCGGACGGAGGCGAGTGGCAGGCCGCGGCCGACAAGGTCGCGCAGGACCTGGGCGTGCCGGTGCACTGCCACCCGGTGGGCGGCGACGGGCAACTGACCGATCCCGACGGCGCGTTCCTCGGCACCACGGGCCTCACCCGGAACGGGGCGCTGCTGATCCGGCCGGACGGCTTCGTGGCGTGGCGGGCCGAGTACCTGCCGGAGGACGCCGCCGGGGAGCTGCGGTCCGCACTGGAGCGGATCCTGGCGCGGACCTCCGGCACGCCCGGCGGCACGGCGCTGGAGGGCTGA	MEKHRGTTVLTRASGISSRTMELLRGVGLERTVIERGPKLVEGARWRELGQPADQIPWVVIRANGLHDLENAVTVEEPSLDVGHLSPTRPYWCGQDRLEPILRDEAVRRGARIDFNTRMEAFTADESGVTATIVDQATGEQSTVRARYLIAADGVRSPVRETLGITRTGHGTIGNAMSVLFKADLRDTVKGRRFVICYLPNPDEPGVLQLPEVPAVLQLFDEDRWIFGFFFDPRETSPEQFTDERCAQIIRTATGLPGLPVEVQMARPWEMSHNSARSYRSGRVFLAGDAAHVHPPAGAFGANGGIQDAHNLAWKLAAVLKGTAGDALLDTYEQERLPIGAAVADQAWIRHTWRLNDSEELRRALRESTLVATGYRYTSDAVLGAAYPEPIPAAHDLTGRPGYRVPHVWLGRGGERVSTVDLGGDAFVVLAGPDGGEWQAAADKVAQDLGVPVHCHPVGGDGQLTDPDGAFLGTTGLTRNGALLIRPDGFVAWRAEYLPEDAAGELRSALERILARTSGTPGGTALEG	MSDVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLDKFLAHGRKYPLGGFFAGISKPAPAHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGKRVVAIRQDTDNVAAELSDGTTLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEMDVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTLDDIKQQLLAIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELMEFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGNLYDLMRSGRGLLLDQGGQLSVDGWSDRADHIVDTSTELEAPAVLLRPDGHVAWIGDAQAELDTQLSTWFGRSARDRA	110.23	gnl|BL_ORD_ID|729|hsp_num:0	796			108	1425	rifampin; rifaximin; rifabutin; rifapentine
BGC0000275.1|Tetracenomycin_5 # 5644 # 5982 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.681	BGC0000275.1|Tetracenomycin_5 	5644	5982	+	Loose	1700	25.0238	AxyY	41.67	3004144	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCGACCATCTCCCCCTCGCCGGACCTGTTCACCCTCGTCAACGTCTTCGGCGTCGCCCCCGAGAAGCAGCGGGAACTGCGCGACCACCTGGTGCAGGTGACCGAGGACCTGATCCGGCACATGCCGGGTTTCGTCTCCGCGACCTTCCACCTCAGCCGCGACGGCGAACAGGTCGTCAACTACGCACAGTGGCGGTCGGAGGCCGACTTCCGCGCCATGCACGCCGACCCGCGGCTGCAGCCCCACTTCGACTACTGCCGGTCCGTGTCCCGGCCGAAGCCGATCTTCTGCGAGGTCACCCACTCCTTCGGCGCCACGTCACCGGAGGGAGCGTGA	MATISPSPDLFTLVNVFGVAPEKQRELRDHLVQVTEDLIRHMPGFVSATFHLSRDGEQVVNYAQWRSEADFRAMHADPRLQPHFDYCRSVSRPKPIFCEVTHSFGATSPEGA	MARFFIDRPVFAWVISLLIALVGLLSIRALPVAQYPDIAPPVVNIGASYPGASAKVVEEAVTAIIEREMNGAPGLMYTSSSSDSTGWASINLTFKQGTNPDIAAVEVQNRLKAVEPRLPESVRRDGVRVEKAADNIQLVVSLKSDGSLDDMQLGELAASNVLQALRRVEGVGKVQSFGAEAAMRIWPDPAKLTALSLTPGDIVSALRSHNARVTIGELGNQAVPKDAPLNASIVAGESLHTPEQFANIPLRALPDGATLRLKDVARVELGGTDYMYLSRVNGLTGTGLGIKLAPGSNAVETTRRIRETMRELAQYFPPGVTWDIPYETSTFVEISIKKVLMTLLEAVALVFCVMYLFMQNLRATLIPTLVVPVALLGTLGVMLGLGYSINVLTMFGMVLAIGILVDDAIVVVENVERIMAEEGLSPHDATVKAMGQISGAIVGITVVLVSVFVPMAFFDGAVGNIYRQFAVTLAVSIAFSAFLALSLTPALCASLLKPVPAGHHEKRGFFGWFNRAFARLTTRYTARVAGVLARPVRFGLAYALVIGVAALLFARLPSSFLPDEDQGSFMAMVILPQGSPQAETMAVVKDVERYMMEHEPVQYVYSVNGFSQYGSGPNSAMFFVTLKDWKERRDASQHVDAVVKRINKAFADRKNLMVFALNSPPLPDLGSTSGFDFRLQDRGGLGYEALTQARQKLLAKAAEHPALTDVVFAGQEEAPQLQLRVDRDKAQAMGVPIDEINTALAVMYGSDYIGDFMLNGQVRRVMVQADGKRRVDVDDISRLHVRNLQGQMVPLSAFATLTWSMGPPQLNRYNGFPSFTINGSAARGHSSGEAMRAMETLAAELPRGIGFDWSGQSYEERLSGNQAPVLFALSVLIVFLALAALYESWSIPLAVILVVPLGVIGALLGVTVRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVRDGQGILSATLEAARLRLRPIVMTSLAFGVGVLPLALATGAASGAQAAIGTGVLGGIITATVLAVFLVPLFFLIVGRMVGMRARPARPDGREPLETTP	10.72	gnl|BL_ORD_ID|2411|hsp_num:0	2799			2814	2886	erythromycin; cefepime
BGC0000275.1|Tetracenomycin_7 # 6361 # 6777 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.705	BGC0000275.1|Tetracenomycin_7 	6361	6777	+	Loose	300	26.5646	tet(32)	27.14	3000196	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	GTGGCAGCCGCCGCCAAGATCGCCATGTCCAGTGTGGCGCCCAGTCACCGGCAGGGGGGCAGCACCCGCGCCCTGCTGACGCCGTCGTCGGTGGGTGCGACCTCCGGATTCCTCGGCCACATCGAACTGGCGCCCGGGGAGTCCGTCACCGAGCACTACCACCCGTTCTCGGACAAGTACCTGTACCTGATCGAAGGGAGCCTCGTGGTCCGGGTGAACGGCGAGGAGGTGCGCCTGGAGCGGGACGAGGCCCTGTTCGTGACCCGGGGCCAGCGGCACCGCATCGAGAACCGAGGAAACGTTCCTGCACGGGTGGTCTTCCAGATCTCGCCGCTCGCCCCGCGGCCCGAACTCGGCCATGTCGACACCGAGCCCGTGCCGAACCCGGCGGCGGCGCCGCCGAAGGTGGGAGGCTGA	MAAAAKIAMSSVAPSHRQGGSTRALLTPSSVGATSGFLGHIELAPGESVTEHYHPFSDKYLYLIEGSLVVRVNGEEVRLERDEALFVTRGQRHRIENRGNVPARVVFQISPLAPRPELGHVDTEPVPNPAAAPPKVGG	MKIINIGILAHVDAGKTTLTESLLYTSGAIAEQGNVDKGTTRTDTMILERQRGITIQTAVTSFYWNDYKINIVDTPGHMDFLTEAYRSLSVLDGAVLVISAKDGVQAQTRILFHALQKMDIPTIIFINKIDQNGIDLQCVYQSIKDKLTSDMIVMQEVSLSPKITMTDISDLDKWDMIISGSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAIIETFITETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDTLLLSKKEKIKITEMCIPSNGEIVPADHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREALLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIYLERPQKKASCTIHIEVPPNPFWASIGLTVTPLPVGSGTQYKSEVSLGYLNQSFQNAVMEGVRYGMEQGLYGWGVTDCQICFDYGVYYSPVSTPADFRFLAPVVLEQALKKAGTQLLEPYLSFTLFAPQEYLSRAYNDAPKYCAIIESTRLEKDEVIFKGEIPARCIGEYRNDLNFYTNGRSVCITELKGYQETSGEPVFQPRRPNSRLDKIRHMFQKIM	21.60	gnl|BL_ORD_ID|1220|hsp_num:0	1233			1614	1758	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000275.1|Tetracenomycin_8 # 6779 # 8059 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.721	BGC0000275.1|Tetracenomycin_8 	6779	8059	+	Loose	750	194.126	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	36.34	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGACCCGGCACGCGGAGAAGCGGGTGGTGATCACCGGCATCGGTGTGCGAGCCCCGGGAGGCGCCGGAACCGCGGCCTTCTGGGACCTGCTCACCGCCGGACGCACCGCCACCAGGACGATCTCCCTGTTCGACGCCGCGCCCTACCGGTCCCGGATAGCCGGAGAGATCGACTTCGACCCGATCGGCGAGGGCCTGTCGCCCCGGCAGGCGTCGACGTACGACCGGGCCACGCAGCTCGCCGTCGTCTGCGCCCGCGAGGCGCTGAAGGACAGCGGGCTGGACCCGGCCGCGGTGAACCCGGAACGGATCGGGGTGAGCATCGGCACCGCCGTCGGCTGCACCACCGGCCTCGACCGCGAGTACGCGCGGGTCAGCGAGGGCGGCTCGCGCTGGCTGGTCGACCACACGCTCGCGGTGGAGCAGCTCTTCGACTACTTCGTCCCGACCTCCATCTGCCGGGAGGTCGCCTGGGAGGCGGGGGCCGAGGGACCGGTGACGGTGGTGTCGACCGGGTGCACCTCGGGCCTCGACGCCGTCGGATACGGCACGGAGCTCATCCGGGACGGGCGCGCCGACGTGGTCGTCTGCGGCGCCACCGACGCGCCGATCTCCCCCATCACCGTGGCCTGCTTCGACGCCATCAAGGCGACGTCGGCCAACAACGACGACCCGGCCCACGCCTCCCGCCCCTTCGACCGCAACCGCGACGGCTTCGTGCTCGGGGAGGGCTCGGCGGTCTTCGTCCTGGAGGAGCTGTCCGCCGCCCGCCGGCGAGGAGCGCACGCCTACGCGGAGGTCCGCGGCTTCGCCACACGGTCGAACGCCTTCCACATGACCGGTCTGAAGCCGGACGGCAGGGAGATGGCGGAGGCCATCACCGCCGCCCTGGACCAGGCCCGCCGCACCGGCGACGACCTGCACTACATCAACGCGCACGGCTCCGGCACCCGGCAGAACGACCGGCACGAGACGGCGGCCTTCAAGCGCAGCCTGGGGCAACGGGCGTACGACGTGCCCGTCAGCTCCATCAAGTCCATGATCGGCCACTCGCTCGGAGCGATCGGCTCCCTCGAACTGGCCGCCTGCGCGCTGGCGATCGAACACGGCGTGATCCCGCCCACCGCCAACTACGAGGAACCCGACCCCGAATGCGACCTCGACTACGTGCCGAACGTCGCGCGGGAACAGCGGGTCGACACCGTGCTCAGCGTCGGCAGCGGATTCGGCGGCTTCCAGAGCGCCGCGGTGCTGGCCCGGCCGAAGGAGACCCGCTCATGA	MTRHAEKRVVITGIGVRAPGGAGTAAFWDLLTAGRTATRTISLFDAAPYRSRIAGEIDFDPIGEGLSPRQASTYDRATQLAVVCAREALKDSGLDPAAVNPERIGVSIGTAVGCTTGLDREYARVSEGGSRWLVDHTLAVEQLFDYFVPTSICREVAWEAGAEGPVTVVSTGCTSGLDAVGYGTELIRDGRADVVVCGATDAPISPITVACFDAIKATSANNDDPAHASRPFDRNRDGFVLGEGSAVFVLEELSAARRRGAHAYAEVRGFATRSNAFHMTGLKPDGREMAEAITAALDQARRTGDDLHYINAHGSGTRQNDRHETAAFKRSLGQRAYDVPVSSIKSMIGHSLGAIGSLELAACALAIEHGVIPPTANYEEPDPECDLDYVPNVAREQRVDTVLSVGSGFGGFQSAAVLARPKETRS	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	102.40	gnl|BL_ORD_ID|1968|hsp_num:0	1943			306	1245	isoniazid
BGC0000275.1|Tetracenomycin_9 # 8056 # 9285 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.750	BGC0000275.1|Tetracenomycin_9 	8056	9285	+	Loose	600	26.1794	Acinetobacter baumannii AmvA	25.33	3004577	protein homolog model	n/a	n/a	macrolide antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGCGCGCCGGCCCCCGTCGTGGTCACCGGCCTGGGCATCGTGGCACCCAACGGCACCGGCACCGAGGAGTACTGGGCGGCCACGCTCGCCGGCAAGAGCGGCATCGACGTCATCCAGCGGTTCGACCCCCACGGCTACCCCGTCCGGGTGGGAGGCGAGGTGCTGGCCTTCGACGCCGCCGCCCATCTCCCCGGGCGCCTGCTGCCGCAGACCGACCGCATGACCCAGCACGCCCTGGTGGCCGCCGAATGGGCCCTGGCCGACGCCGGGCTGGAGCCCGAGAAGCAGGACGAGTACGGCCTCGGCGTCCTGACGGCCGCCGGCGCGGGAGGGTTCGAGTTCGGCCAGCGCGAGATGCAGAAACTCTGGGGAACGGGCCCGGAACGCGTCAGCGCCTACCAGTCGTTCGCCTGGTTCTACGCGGTGAACACCGGCCAGATCTCCATCCGCCACGGCATGCGCGGGCACAGCTCCGTGTTCGTCACCGAGCAGGCCGGCGGTCTCGACGCCGCCGCCCACGCGGCCCGCCTGCTGCGCAAGGGGACCCTGAACACCGCCCTGACCGGCGGATGCGAAGCCTCCCTCTGCCCCTGGGGCCTGGTCGCCCAGATCCCGAGCGGCTTCCTGAGCGAGGCCACCGACCCGCACGACGCCTACCTGCCCTTCGACGCGCGGGCGGCCGGGTACGTGCCCGGCGAGGGCGGAGCCATGCTGGTCGCCGAGCGGGCGGACTCCGCACGCGAACGGGACGCCGCCACGGTCTACGGGAGGATCGCCGGGCACGCCTCCACCTTCGACGCCCGCCCCGGCACCGGCCGGCCCACCGGGCCGGCCCGGGCCATCCGCCTGGCCCTCGAAGAGGCCCGGGTCGCGCCCGAGGACGTCGACGTGGTCTACGCCGACGCCGCTGGAGTGCCGGCCCTCGACCGCGCGGAGGCGGAGGCCCTCGCCGAGGTCTTCGGGCCCGGGGCCGTACCGGTCACCGCGCCCAAGACGATGACCGGACGGCTCTACGCCGGGGGAGCGGCCCTCGACGTCGCGACCGCGCTGCTGTCCATCAGGGACTGTGTCGTCCCGCCGACCGTCGGCACCGGTGCGCCCGCGCCGGGGCTCGGCATCGACCTGGTGCTCCACCAGCCCCGTGAGCTGCGGGTGGACACCGCCCTGGTCGTCGCGCGGGGCATGGGCGGATTCAACTCCGCCCTGGTCGTCCGGCGCCACGGCTGA	MSAPAPVVVTGLGIVAPNGTGTEEYWAATLAGKSGIDVIQRFDPHGYPVRVGGEVLAFDAAAHLPGRLLPQTDRMTQHALVAAEWALADAGLEPEKQDEYGLGVLTAAGAGGFEFGQREMQKLWGTGPERVSAYQSFAWFYAVNTGQISIRHGMRGHSSVFVTEQAGGLDAAAHAARLLRKGTLNTALTGGCEASLCPWGLVAQIPSGFLSEATDPHDAYLPFDARAAGYVPGEGGAMLVAERADSARERDAATVYGRIAGHASTFDARPGTGRPTGPARAIRLALEEARVAPEDVDVVYADAAGVPALDRAEAEALAEVFGPGAVPVTAPKTMTGRLYAGGAALDVATALLSIRDCVVPPTVGTGAPAPGLGIDLVLHQPRELRVDTALVVARGMGGFNSALVVRRHG	MQKKWLILTIIVLIYLPVTIDATVMHVATPSLSAALNLTANQLLWIIDIYSLIMAGLILPMGALGDRIGFKKLLFIGTAVFGVGSLAAAFSPTAYALIASRAILGLGAAMLIPATLSGIRNAFTEEKQRNFALGIWSTVGGGGAAFGPLVGGFVLEHFHWGAVFLINIPIILAVLVMIVMIIPKQQEKTDQPINLGQALVLVVAILSLIYSIKSAMYNFSVLTVVMFVVGISTLIHFIRSQKRATTPMIDLELFKHPVISTSIVMAVVSMIALVGFELLLSQELQFVHGFSPLQAAMFIIPFMIAISLGGPLAGICLNKWGLRRVSSLGILVSALSLWGLAQLNFSTDHFLAWTCMVFLGFSIEIALLASTAAIMSSVPPQKASAAGAIEGMAYELGAGLGVAIFGLMLSWFYSRSIILPAELPSNLIEKASISIGETMQLASNLENPLGGQLIVVAQQAFSYAHSWVLTLSAICFFLLTVFVWFSFPKKVN	83.13	gnl|BL_ORD_ID|2718|hsp_num:0	3280			267	441	erythromycin; acriflavine
BGC0000275.1|Tetracenomycin_11 # 9611 # 11095 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.693	BGC0000275.1|Tetracenomycin_11 	9611	11095	+	Loose	500	31.9574	chrB	38.6	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGGCAGCGCGCACGGACAACTCCATCGTCGTCAACGCGCCGTTCGAGCTCGTCTGGGACGTCACCAACGACATCGAGGCATGGCCGGAGCTGTTCTCCGAGTACGCCGAGGCGGAGATCCTCCGGCAGGACGGCGACGGCTTCGACTTCCGGCTCAAGACCCGCCCCGACGCGAACGGAAGGGTCTGGGAGTGGGTCTCCCACCGTGTGCCCGACAAGGGCTCCCGCACGGTCCGGGCGCACCGCGTCGAGACCGGGCCCTTCGCCTACATGAACCTGCACTGGACCTACCGGGCCGTGGCCGGGGGCACCGAGATGCGGTGGGTGCAGGAGTTCGACATGAAGCCCGGGGCCCCGTTCGACAACGCGCACATGACCGCTCACCTCAACACGACGACACGGGCGAACATGGAGCGCATCAAGAAGATCATCGAGGACAGGCACCGGGAAGGACAGCGGACCCCGGCGTCCGTCCTGCCCACCGAACTGCACGCCCAGCAACTGCTGTTGCTGGCCGCCTCCGGGCGCCTGGCGCGGATCGTCCACGTGCTGACCGAGCTGAGGATCGCCGATCTCCTCGCCGACGGCCCCCGTCACGTCGCGGAACTGGCCAAGGAGACGGACACCCACGAGCTCTCCCTCTACCGCGTCCTGCGCAGCGCCGCCTCCGTCGGCGTCTTCGCGGAGGGGCCCGTCAGGACCTTCTCCGCGACGCCCCTGTCGGACGGACTGCGCACCGGCAACCCGGACGGTGTGCTGCCCCTGGTGAAGTACAACAACATGGAGCTGACCAGGCGGCCCTACGACGAGATCATGCACAGTGTGCGCACCGGCGAACCGGCCTTCCGGCGGGTGTTCGGCAGCTCGTTCTTCGAGCACCTGGAGGCCAACCCGGAAGCCGGCGAGTTCTTCGAGCGGTTCATGGCCCACTGGAGCCGCCGGCTCGTCCTCGACGGACTCGCCGACCAGGGCATGGAGCGCTTCTCGCGCATCGCGGACCTCGGCGGTGGCGACGGCTGGTTCCTCGCCCAGATCCTCCGGCGCCACCCGCACGCCACGGGCCTGCTCATGGACCTCCCGCGGGTGGCCGCGTCGGCCGGCCCCGTCCTGGAGGAGGCCAAAGTCGCCGACCGGGTCACCGTGCTGCCCGGCGACTTCTTCACGGACCCCGTCCCCACCGGCTACGACGCCTACCTCTTCAAGGGCGTGCTGCACAACTGGTCCGACGAGCGGGCCGTGACCGTGCTGCGCCGGGTCCGGGAGGCCATCGGCGACGACGACGCACGCCTGCTGATCTTCGACCAGGTCATGGCCCCCGAGAACGAGTGGGACCACGCCAAGCTGCTGGACATCGACATGCTGGTGCTCTTCGGAGGCCGCGAACGGGTGCTGGCCGAGTGGCGGCAGCTGCTGCTCGAGGCGGACTTCGACATCGTCAACACGCCCTCCCACACCTGGACCACGCTGGAGTGCCGCCCCGTCTAG	MAARTDNSIVVNAPFELVWDVTNDIEAWPELFSEYAEAEILRQDGDGFDFRLKTRPDANGRVWEWVSHRVPDKGSRTVRAHRVETGPFAYMNLHWTYRAVAGGTEMRWVQEFDMKPGAPFDNAHMTAHLNTTTRANMERIKKIIEDRHREGQRTPASVLPTELHAQQLLLLAASGRLARIVHVLTELRIADLLADGPRHVAELAKETDTHELSLYRVLRSAASVGVFAEGPVRTFSATPLSDGLRTGNPDGVLPLVKYNNMELTRRPYDEIMHSVRTGEPAFRRVFGSSFFEHLEANPEAGEFFERFMAHWSRRLVLDGLADQGMERFSRIADLGGGDGWFLAQILRRHPHATGLLMDLPRVAASAGPVLEEAKVADRVTVLPGDFFTDPVPTGYDAYLFKGVLHNWSDERAVTVLRRVREAIGDDDARLLIFDQVMAPENEWDHAKLLDIDMLVLFGGRERVLAEWRQLLLEADFDIVNTPSHTWTTLECRPV	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	176.43	gnl|BL_ORD_ID|274|hsp_num:0	305			276	444	tylosin; chalcomycin; mycinamicin
BGC0000275.1|Tetracenomycin_12 # 11192 # 12211 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.716	BGC0000275.1|Tetracenomycin_12 	11192	12211	+	Loose	400	28.4906	ErmS	44.0	3001304	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACACCGCACACGCACGTCCGCGGACCGGGCGACATCCTCCAGCTGACCATGGCCTTCTACGGATCGCGCGCCCTCATCAGCGCGGTCGAACTGGACCTGTTCACCCTGCTCGCCGGGAAACCGCTGCCGCTCGGCGAGCTGTGCGAGCGGGCGGGCATCCATCCTCGCGGCGCGCGGGACTTCCTCGACGCCCTGGTGGCACTGGGACTCCTGGAGCGCGAGGGCGAGGACACCTACCGCAACAGCCCGGCCGCCGACCGCCATCTGGACCGGCGCAAGCCCGGGTACGTCGGCGGCTACGCCCGGCTCGCGGACACCAAGCTGTTCCCCGTCTGGGCACGGCTGACGGAGGCCCTGCGCACGGGCGAGAAGCAGGTGCCGAGCCAGGGCGGCTTCTTCGGCGGCTACGCGGACCCGGAGGCGGCCCGCGGCTTCCTCGGCGCCATGGACGCCGTCAACGGCGGCGTCGGGCACAGCCTGGCCGGCGCGCTCGACTGGACGGAGTACTCCTCCTTCGTCGACCTCGGCGGCGCGCGCGGCAACCTCGCCGCGCACCTGCACCGGGCTCACCCGCACCTGCGGGCCACCTGTTTCGACCTGCCGGAGATGGAACCCTTCTTCCAGGAGCACATGAAGTCCCTGGAGACGACGGACCAGGTGCGCTTCGCCGGGGGCGACTTCTTCACCGACCCCCTGCCGCGCGCGGACGTGTTCATCGTCGGGCACATCCTCCACTACTTCGGTCTCCGGCAGCGCGAGGCGCTGATCGCCCGCATCCACCAGGCGCTCACCCCGGGCGGTGCCGTCCTCGTCTACGACCGGATGATCGACGACGACCGGCGCAGTGCCGCACTGAGCCTGCTCGGCAGCCTCAACATGCTGCTGACCTCCGACGAGGGACGCGAGTACACCCCCGCGGAGTGCGTCCGGTGGCTGTCCGACGCCGGATTCACCGACGTCCGCACCACCGCGGTGAGCGGGCCCGACACCCTCGCGATCGGCCGCAAACCCCGGTGA	MTPHTHVRGPGDILQLTMAFYGSRALISAVELDLFTLLAGKPLPLGELCERAGIHPRGARDFLDALVALGLLEREGEDTYRNSPAADRHLDRRKPGYVGGYARLADTKLFPVWARLTEALRTGEKQVPSQGGFFGGYADPEAARGFLGAMDAVNGGVGHSLAGALDWTEYSSFVDLGGARGNLAAHLHRAHPHLRATCFDLPEMEPFFQEHMKSLETTDQVRFAGGDFFTDPLPRADVFIVGHILHYFGLRQREALIARIHQALTPGGAVLVYDRMIDDDRRSAALSLLGSLNMLLTSDEGREYTPAECVRWLSDAGFTDVRTTAVSGPDTLAIGRKPR	MARAPRSPHPARSRETSRAHPPYGTRADRAPGRGRDRDRSPDSPGNTSSRDGGRSPDRARRELSQNFLARRAVAERVARLVRPAPGGLLLEVGAGRGVLTEALAPYCGRLVAHEIDPRLLPALRDRFGGPHHAHVRISGGDFLAAPVPREPFALAGNIPYSRTAGIVDWALRARTLTSATFVTQLEYARKRTGDYGRWSLLTVRTWPRHEWRLLGRVSRREFRPVPRVDSGILRIERRERPLLPSAALGDYHRMVELGFSGVGGSLYASLRRAHRAGPLDAAFRAARLDRSVVVAYVTPEQWLTVFRTLRPVRSRPAGR	106.27	gnl|BL_ORD_ID|671|hsp_num:0	727			399	474	lincomycin; tylosin; pristinamycin IC; carbomycin; niddamycin
BGC0000275.1|Tetracenomycin_13 # 12208 # 12405 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.768	BGC0000275.1|Tetracenomycin_13 	12208	12405	+	Loose	275	24.2534	AAC(6')-Ii	31.25	3002556	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	GTGAGGTGGCTCGGCAGGACCGTCTGGCTGGGGCTGATCGGCCTCGGCGCGTTCTGGACCGGGCACCTGCCCCCCGGCCCGTACGGGCAGGACCGGGCCGGGTCCGCCCCGCCGGCCGGACACCCGGAACGGCTCGTCCCCACGGCGCTCACCGCCCAGGAGCTGATCCTGTCGCGCGAGCTGGGCTGGACCCGCTGA	MRWLGRTVWLGLIGLGAFWTGHLPPGPYGQDRAGSAPPAGHPERLVPTALTAQELILSRELGWTR	MIISEFDRNNPVLKDQLSDLLRLTWPEEYGDSSAEEVEEMMNPERIAVAAVDQDELVGFIGAIPQYGITGWELHPLVVESSRRKNQIGTRLVNYLEKEVASRGGITIYLGTDDLDHGTTLSQTDLYVHTFDKVASIQNLREHPYEFYEKLGYKIVGVLPNANGWDKPDIWMAKTIIPRPDSQ	35.71	gnl|BL_ORD_ID|1042|hsp_num:0	1050			75	171	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000275.1|Tetracenomycin_14 # 12657 # 13121 # -1 # ID=1_14;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.783	BGC0000275.1|Tetracenomycin_14 	12657	13121	-	Loose	550	26.5646	lnuF	26.76	3002839	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic inactivation	lincosamide nucleotidyltransferase (LNU)	TACCTGGAGATCATCGGCCCGGACCCGGAGCAGCCCGCCCCGGCCGGCCCGCGGCCGTTCGGCGTGGACCTGCTGCCCGGCCCGCGCACCGTGACCTGGGCGATCCGCACGACCGACCTGGACGCGGCGATCGCCTCGGCCCGCGCCCGCGGCCACGATCCCGGTCCCGCCCGGGCGATGAGCCGCCGCACGCCCGACGGCGCCCTGCTGGAGTGGCGGCTGACGGACGGTTCCGCCCACCCGTCCGGGCTGGTGCCCTTCCTCATCGACTGGGGCGCCTCCCGCCACCCCACCGCCGCCGGGCTGCCCGTCACCCCCTTGCTGCGGCTGTCGGCGACGGCTCCCGACCCGGCGGAGATCCGCCCCCTGCTGGCCGCCCTGGACACCGGGCTGGCCCTCGCCGAGGGGCCGGCCGGGTTCTCCTTCACGGTCGGCACACCGCGCGGCCCGGTCACCTTCACCTGA	YLEIIGPDPEQPAPAGPRPFGVDLLPGPRTVTWAIRTTDLDAAIASARARGHDPGPARAMSRRTPDGALLEWRLTDGSAHPSGLVPFLIDWGASRHPTAAGLPVTPLLRLSATAPDPAEIRPLLAALDTGLALAEGPAGFSFTVGTPRGPVTFT	MLQQKMIERFKEACHEDARIIAALMFGSFAIGEGDEFSDIEFAVFIQNNHFENFDQRSWLNAVSPVAAYFPDDFGHHTALFENGIRGEFHFMRKSDIPVISTWQGYGWFPSLEEAVLLDRSGELSRYASALVGSPPKREGAPLVEGLVLNLISLMLFGANLLNRGEYARAWALLSKAHENLLKLVRLHEGATDHWPTPSRALEKDVSEDSYNRYLACTGSAEPKALCVAYHETWKWSLELFRSVAGPLNIELPRIVIAQTKRLLNESATPHNK	56.41	gnl|BL_ORD_ID|1373|hsp_num:0	1491			468	681	lincomycin; clindamycin
